Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-a in carotid atherosclerotic plaques

European Journal of Vascular and Endovascular Surgery

Volumn 30, Issue 1, 2005, Pages 41-47

  Migdalski, Armigos ^a,b   Kotschy, M ^a   Jawien, A ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Department of Surgery   (Poland)

Author keywords

Arteriosclerosis; Blood coagulation factors; Carotid stenosis; Endothelial growth factors

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN A;

ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; TISSUE HOMOGENATE;

AGED; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LIPOPROTEINS; MALE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOPLASTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20144377497     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.02.055     Document Type: Article

References (42)

1. H. Kato Regulation of functions of vascular wall cells by tissue factor pathway inhibitor. Basic and clinical aspects Arterioscler Thromb Vasc Biol 2002 539-548
2. D. Ardissino P.A. Merlini R. Ariens R. Coppola E. Bramucci P.M. Mannucci Tissue-factor antigen and activity in human coronary atherosclerotic plaques Lancet 349 1997 769-771
3. D. Corseaux T. Le Tournaeu I. Six M.D. Ezekowitz E.P. McFadden T. Meurice et al. Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine Circulation 98 1998 1776-1782
4. D. Hasenstab H. Lea C.E. Hart S. Lok A.W. Clowes Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis Circulation 101 2000 2651-5657
5. P.R. Moreno V.H. Bernardi J. López-Cuëllar A.M. Muria I.F. Palacios H.K. Gold et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes Circulation 94 1996 3090-3097
6. V. Toschi R. Gallo M. Lettino J.T. Fallon S.D. Gertz A. Fernández-Ortiz et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594-599
7. E. Camerer W. Huang S.R. Coughlin Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa Proc Natl Acad Sci U S A 97 2000 5255-5260
8. M. Riewald W. Ruf Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor Proc Natl Acad Sci U S A 98 2001 7742-7747
9. J. Waltenberger Modulation of growth factor action: Implications for the treatment of cardiovascular diseases Circulation 96 1997 4083-4095
10. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia Circulation 97 1998 1114-1123
11. J. Folkman Angiogenic therapy of the human heart Circulation 97 1998 628-629
12. P. Carmeliet V. Ferreira G. Breier S. Pollefeyt L. Kieckens M. Gertsenstein et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435-439
13. N. Ferrara K. Carver-Moore H. Chen M. Dowd L. Lu K.S. O'Shea et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 1996 439-442
14. K.D. O'Brien T.O. McDonald A.A. Chait M.D. Allen C.E. Alpers Neovascular expression of E-selection, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to initial leukocyte content Circulation 93 672 1996 682
15. A. Migdalski A. Jawien M. Kotschy A. Knapik-Bieniek Selected haemostatic factors in carotid bifurcation plaques of patients undergoing carotid endarterectomy Eur J Vasc Endovasc Surg 27 2 2004 172-179
16. M. Kotschy A. Knapik-Bieniek A. Migdalski A. Jawien D. Kotschy Selected markers of endothelium activity in carotid plaques of patients undergoing carotid endarterectomy Acta Haematol Pol Suppl 2 2003 34
17. E.G. Grant C.B. Benson G.L. Moneta A.V. Alexandrov J.D. Baker E.I. Bluth et al. Carotid artery stenosis: Grayscale and Doppler ultrasound diagnosis - Society of Radiologists in ultrasound consensus conference Ultrasound Q 19 4 2003 190-198
18. R. Ross The pathogenesis of atherosclerosis: A perspective for the 1990's Nature 363 1993 801-809
19. S. Jander M. Sitzer R. Schumann M. Schroeter M. Siebler H. Steinmetz et al. Inflammation in high-grade carotid stenosis: A possible role for macrophages and T-cells in plaque destabilization Stroke 29 1998 1625-1630
20. S. Jander M. Sitzer A. Wendt M. Schroeter M. Buchkremer M. Siebler et al. Expression of tissue factor in high-grade carotid artery stenosis Stroke 32 2001 850-854
21. B.H. Annex S.M. Denning K.M. Channon M.H. Sketch R.S. Stack J.H. Morrissey et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes Circulation 91 1995 619-622
22. J.N. Wilcox K.M. Smith S.M. Schwartz D. Gordon Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque Proc Natl Acad Sci U S A 86 1989 2839-2843
23. T. Koyama K. Nishida S. Ohdama M. Sawada N. Murakami S. Hirosawa et al. Determination of plasma tissue factor antigen and its clinical significance Br J Haematol 87 1994 343-347
24. S. Albrecht M. Kotzsch G. Siegert T. Luther H. Grossmann M. Grosser et al. Detection of circulating tissue factor and factor VII in a normal population Thromb Haemost 75 1996 772-777
25. K. Misumi H. Ogawa H. Yasue H. Soejima H. Suefuji K. Nishiyama et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris Am J Cardiol 81 1998 22-26
26. H. Soejima H. Ogawa H. Yasue K. Kaikita K. Nishiyama K. Misumi et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina Circulation 99 1999 2908-2913
27. D. Bonderman A. Teml J. Jakowitsch C. Adlbrecht M. Gyongyosi W. Sperker et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque Blood 99 2002 2794-2800
28. N.M. Caplice C.S. Mueske L.S. Kleppe R.D. Simari Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity Circulation 98 1998 1051-1057
29. K. Kaikita M. Takeya H. Ogawa H. Suefuji H. Yasue K. Takahashi Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis J Pathol 188 1999 180-188
30. J. Crawley F. Lupu A.D. Westmuckett N.J. Severs V.V. Kakkar C. Lupu Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels Arterioscler Thromb Vasc Biol 20 2000 1362-1373
31. M. Diamant R. Nieuwland R.F. Pablo A. Sturk J.W. Smit J.K. Radder Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus Circulation 106 2002 2442-2447
32. T. Asahara C. Bauters C. Pastore M. Kearney S. Rossow S. Bunting et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery Circulation 91 1995 2793-2801
33. J. Waltenberger J. Lange A. Kranz Vascular endothelial growth factor-A - induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus Circulation 102 2000 185-190
34. N. Ferrara H. Chen T. Davis-Smyth H.P. Gerber T.N. Nguyen D. Peers et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis Nat Med 4 3 1998 336-340
35. P. Carmeliet N. Mackman L. Moons T. Luther P. Gressens I. Van Vlaenderen et al. Role of tissue factor in embryonic blood vessel development Nature 383 1996 73-75
36. H. Lappalainen P. Laine M.O. Pentikäinen A. Sajantila P.T. Kovanen Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator Arterioscler Thromb Vasc Biol 24 2004 1880
37. S.J.H. Wielders S. Béguin H.C. Hemker T. Lindhout Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available Arterioscer Thromb Vasc Biol 24 2004 1138-1142
38. M. Moser C. Patterson Thrombin and vascular development Arterioscer Thromb Vasc Biol 23 2003 922
39. D.E. Richard E. Berra J. Pouyssegur Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells J Biol Chem 275 2000 26765-26771
40. C.A. McNamara I.J. Sarembock L.W. Gimple J.W.I. Fenton S.R. Coughlin G.K. Owens Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor J Clin Invest 91 1993 94-98
41. C. Patterson G.A. Stouffer N. Madamanchi M.S. Runge New tricks for old dogs nonthrombotic effects of thrombin in vessel wall biology Circ Res 88 2001 987-997
42. S. Zucker H. Mirza C.E. Conner A.F. Lorenz M.H. Drews W.F. Bahou et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation Int J Cancer 75 1998 780-786